Atrion develops and manufactures products, primarily for medical applications. Co. has developed various proprietary valves designed to fill, hold and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter and other applications in fields such as anesthesia and oncology. Co.'s primary cardiovascular products is the Myocardial Protection System, a proprietary technology that is used in open-heart surgery that delivers to the heart essential fluids and medications, mixes drugs and controls temperature, pressure and other variables. Co. also manufactures balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. The ATRI YTD return is shown above.
The YTD Return on the ATRI YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether ATRI YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the ATRI YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|